ABOUT
Overview
Management
Drug Development Team
Board of Directors
Corporate Partnerships
SCIENCE
Technology Platform
Scientific Publications
PIPELINE
Overview
Piclidenoson (CF101)
Namodenoson (CF102)
CF602
Cannabinoids
INVESTORS
Overview
News & Events
Company Information
Financial Information
Stock Information
SEC Fillings
Corporate Governance
Shareholders Meetings
CONTACT
Menu
×
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
In The News
Research
Events Calendar
Presentations
Email Alerts
Company Info
Overview
Video
Management
Contacts
FAQ
Financial Info
Overview
Financial Results
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Section 16 Filings
Governance
Overview
Board of Directors
Governance Documents
Shareholders Meetings
Filing Type:
View All
20-F
20-F/A
20FR12G
20FR12G/A
3
3/A
424B3
424B4
424B5
424B7
5
6-K
6-K/A
8-A12B
AW
CERTNYS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
F-3/A
F-6
F-6 POS
F-6EF
POS AM
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Date
Form
Description
PDF
XBRL
Pages
12/01/11
3
Statement of changes in beneficial ownership of securities
2
rss_feed
Filing RSS
arrow_back
1
…
65
66
67
68
69
70
71
72
73
74
Email Alerts
Contacts
RSS News Feed
